P11362 (FGFR1_HUMAN) Homo sapiens (Human)
Fibroblast growth factor receptor 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
76 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of activated receptor tyrosine kinase in complex with substrates |
Heteromer P10686; | 98.7 | 1×DVT; 1×ACP; 1×MG; | |||
| Crystal structure of a monomeric human FGF9 in complex with the ectodomain of human FGFR1c |
Heteromer P31371; | 99.04 | 3×SO4; | |||
| Crystal Structure of FGF1 complexed with the ectodomain of FGFR1c exhibiting an ordered ligand spec… |
Heteromer P05230; | 99.53 | 1×SGN; | |||
| CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1… |
Heteromer P05230; | 100.0 | 4×SO4; | |||
| Crystal Structure of a 1:1:1 FGF23-FGFR1c-aKlotho Ternary Complex |
Heteromer Q9GZV9; Q9UEF7; | 99.53 | 7×NAG; 1×ZN; | |||
| Cryo-EM Structure of FGF23-FGFR1c-aKlotho-HS Quaternary Complex |
Heteromer Q9GZV9; Q9UEF7; | 100 | 1×SGN; 1×ZN; 1×CU; | |||
| CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX |
Heteromer P09038; | 99.53 | 4×SO4; | |||
| CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX |
Heteromer P09038; | 99.53 | 1×SGN; 1×SGN; | |||
| Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors |
Heteromer Q8WU20; | 100 | ||||
| Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo… | homo-2-mer | 100.0 | 3×SO4; 3×EDO; 2×2K7; | |||
| Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5… | homo-2-mer | 99.66 | 2×VM1; 2×PO4; | |||
| Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou… | homo-2-mer | 99.64 | 4×SO4; 10×EDO; 2×0S9; | |||
| Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo… | homo-2-mer | 99.64 | 4×EDO; 3×SO4; 2×2K5; | |||
| CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 | homo-2-mer | 100.0 | ||||
| Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou… | homo-2-mer | 100.0 | 2×0S8; 4×EDO; 1×SO4; | |||
| CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074 | homo-2-mer | 100.0 | 2×PD1; | |||
| Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou… | homo-2-mer | 100.0 | 2×0S7; 4×EDO; | |||
| Crystal Structure of activated receptor tyrosine kinase in complex with substrates | monomer | 99.65 | 1×GQL; | |||
| Native FGFR1 with an inhibitor | monomer | 100.0 | 3×CL; 1×38O; | |||
| FGFR1 mutant with an inhibitor | monomer | 99.66 | 1×38O; 2×CL; | |||
| Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETH… | monomer | 99.35 | 1×66T; | |||
| Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain | monomer | 99.67 | 3×SO4; | |||
| Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-… | monomer | 99.02 | 1×66T; 1×MG; | |||
| FGFR1 kinase domain with sulfatinib | monomer | 99.67 | 1×UKI; 6×SO4; 1×GOL; | |||
| Crystal structure of FGFR1 kinase domain with Pemigatinib | monomer | 99.67 | 1×8ZF; 4×SO4; | |||
| FGFR1 kinase domain with a covalent inhibitor 10h | monomer | 99.67 | 3×SO4; 1×A1LWW; | |||
| Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo | monomer | 99.02 | ||||
| Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethox… | monomer | 99.34 | 1×07J; 3×SO4; | |||
| Structure of the mutant Fibroblast Growth Factor receptor 1 | monomer | 99.02 | ||||
| Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11. | monomer | 99.31 | 1×SO4; 2×EDO; 1×O21; | |||
| Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527 | monomer | 99.01 | 1×9ES; 2×SO4; 9×EDO; | |||
| FGFR1 kinase domain with a dual-warhead covalent inhibitor CXF-007 | monomer | 100.0 | 1×A1LVQ; 3×SO4; | |||
| DISEASE LINKED MUTATION IN FGFR | monomer | 98.99 | 1×SO4; 1×ACT; | |||
| FGFR1 in complex with dovitinib | monomer | 100.0 | 3×EDO; 1×38O; 2×SO4; | |||
| FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylph… | monomer | 100.0 | 1×SO4; 1×XL6; | |||
| FGFR1 kinase domain with a covalent inhibitor 9g | monomer | 100.0 | 1×A1LW9; 4×SO4; | |||
| FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693 | monomer | 99.66 | 2×SO4; 1×5SF; | |||
| FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38. | monomer | 100.0 | 1×47I; 2×SO4; 3×EDO; | |||
| FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34. | monomer | 100.0 | 1×42I; 5×SO4; 3×EDO; | |||
| Crystal structure of FGFR1 kinase domain in complex with compound 3 | monomer | 99.66 | 1×AXU; | |||
| Crystal structure of FGFR1 kinase domain in complex with 7n | monomer | 99.66 | 1×4UT; | |||
| TAS-120 in reversible binding mode with FGFR1 | monomer | 99.64 | 1×TZ0; | |||
| FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole | monomer | 99.66 | 1×C4F; | |||
| FGFR1 ligand complex | monomer | 99.66 | 5×SO4; 5×EDO; 1×XOJ; | |||
| FGFR1 kinase complex with inhibitor SN36985 | monomer | 99.64 | 1×YY7; 1×SO4; | |||
| TAS-120 covalent complex with FGFR1 | monomer | 99.64 | 1×TZ0; 1×SO4; | |||
| FGFR1 kinase domain complex with SN37333 in reversible binding mode | monomer | 100.0 | 1×YY9; | |||
| FGFR1 kinase domain complexed with FIIN-1 | monomer | 99.64 | 1×MK9; 1×SO4; | |||
| FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide | monomer | 100.0 | 1×WP1; | |||
| Fibroblast growth factor receptor 1 kinase in complex with JK-P5 | monomer | 99.33 | 3×EDO; 1×JVT; 1×SO4; | |||
| Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22. | monomer | 99.3 | 1×O1Y; 1×SO4; | |||
| Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-… | monomer | 99.29 | 1×66T; | |||
| FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 19. | monomer | 99.65 | 1×466; 1×SO4; 2×EDO; 1×CL; | |||
| Human FGF in complex with a covalent inhibitor | monomer | 99.65 | 1×9K5; 2×SO4; | |||
| Fibroblast growth factor receptor 1 kinase in complex with JK-P3 | monomer | 99.34 | 7×EDO; 1×4Y0; 2×PPI; 4×SO4; | |||
| FGFR1 kinase complex with inhibitor SN37118 | monomer | 100.0 | 1×YY4; | |||
| Human FGF in complex with a covalent inhibitor | monomer | 99.66 | 2×SO4; 1×GOL; 1×9K8; | |||
| Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069 | monomer | 99.64 | 1×3RH; 1×SO4; 1×EDO; | |||
| FGFR1 kinase complex with inhibitor SN37116 | monomer | 99.64 | 1×YY6; | |||
| Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-met… | monomer | 100.0 | ||||
| FGFR1 kinase complex with inhibitor SN37115 | monomer | 99.64 | 1×YY5; 1×SO4; | |||
| FGFR1 Apo structure | monomer | 99.66 | 1×PEG; 3×CL; | |||
| FGFR1 in complex with ponatinib (co-crystallisation). | monomer | 100.0 | 4×SO4; 6×EDO; 1×0LI; | |||
| Human FGFR1 kinase in complex with CH5183284 | monomer | 100.0 | 1×LWJ; 1×SO4; | |||
| FGFR-1 in complex with ligand lenvatinib | monomer | 99.65 | 1×LEV; | |||
| FGFR1 Kinase Domain Soak with Inhibitor TYRA-300 | monomer | 99.64 | 2×EDO; 1×A1AV2; 9×SO4; | |||
| CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W… | monomer | 100.0 | 1×SU2; | |||
| Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor | monomer | 99.65 | 1×960; | |||
| CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W… | monomer | 99.65 | 1×SU1; | |||
| FGFR-1 in complex with ligand tasurgratinib | monomer | 100.0 | 1×A1LY1; 1×CL; | |||
| Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo… | monomer | 100.0 | 1×2M2; | |||
| Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1 | monomer | 100 | ||||
| cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-pi… | monomer | 100.0 | 1×ACT; 1×KRJ; | |||
| cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2… | monomer | 100.0 | 1×KRL; 1×SO4; | |||
| cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor | monomer | 100.0 | 3×SO4; 1×8C5; | |||
| Crystal structure of CSF1R kinase domain in complex with DP-6233 | monomer | 100.0 | 1×NA; 4×CL; 1×I9W; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| 1ry7.1.B | monomer | 0.63 | 58.23 | |||
49 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| Isoform 2 | 1ry7.1.B | monomer | 0.62 | 58.41 | |||
| Isoform 3 | 5a46.1.A | monomer | 0.77 | 1×38O; | 100.00 | ||
| Isoform 3 | 5w59.1.B | monomer | 0.69 | 99.11 | |||
| Isoform 4 | 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| Isoform 4 | 3ojv.2.B | monomer | 0.69 | 99.55 | |||
| Isoform 5 | 5a46.1.A | monomer | 0.77 | 1×38O; | 100.00 | ||
| Isoform 6 | 5a46.1.A | monomer | 0.77 | 1×38O; | 100.00 | ||
| Isoform 7 | 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| Isoform 7 | 1ry7.1.B | monomer | 0.63 | 56.92 | |||
| Isoform 8 | 1e0o.1.D | monomer | 0.69 | 79.05 | |||
| Isoform 8 | 5a46.1.A | monomer | 0.67 | 88.52 | |||
| Isoform 8 | 1ry7.1.B | monomer | 0.64 | 57.99 | |||
| Isoform 8 | 4y61.1.A | monomer | 0.53 | 21.28 | |||
| Isoform 8 | 5xwu.1.C | monomer | 0.53 | 22.42 | |||
| Isoform 8 | 4wrm.1.A | monomer | 0.53 | 17.29 | |||
| Isoform 8 | 4x9i.1.B | monomer | 0.51 | 19.86 | |||
| Isoform 9 | 5a46.1.A | monomer | 0.68 | 88.94 | |||
| Isoform 9 | 1e0o.1.D | monomer | 0.68 | 79.05 | |||
| Isoform 9 | 1ry7.1.B | monomer | 0.63 | 57.99 | |||
| Isoform 9 | 6fwx.1.A | monomer | 0.60 | 19.58 | |||
| Isoform 9 | 5xwu.1.A | monomer | 0.55 | 22.34 | |||
| Isoform 9 | 4y61.1.A | monomer | 0.53 | 21.28 | |||
| Isoform 10 | 1fq9.1.C | monomer | 0.73 | 99.56 | |||
| Isoform 10 | 1e0o.1.B | monomer | 0.71 | 78.67 | |||
| Isoform 10 | 2pzr.1.A | homo-2-mer | 0.69 | 72.02 | |||
| Isoform 11 | 3ojm.1.B | monomer | 0.73 | 69.86 | |||
| Isoform 11 | 1e0o.1.B | monomer | 0.71 | 78.67 | |||
| Isoform 11 | 4j96.1.A | monomer | 0.69 | 72.02 | |||
| Isoform 12 | 3ojm.1.B | monomer | 0.71 | 69.35 | |||
| Isoform 12 | 1e0o.1.B | monomer | 0.69 | 79.10 | |||
| Isoform 12 | 3kxx.1.A | monomer | 0.69 | 85.71 | |||
| Isoform 13 | 3ojm.1.B | monomer | 0.71 | 69.54 | |||
| Isoform 13 | 2pzr.1.A | monomer | 0.71 | 70.62 | |||
| Isoform 13 | 1e0o.1.B | monomer | 0.69 | 79.10 | |||
| Isoform 14 | 5a46.1.A | monomer | 0.77 | 1×38O; | 100.00 | ||
| Isoform 14 | 3ojv.2.B | monomer | 0.69 | 99.55 | |||
| Isoform 15 | 2ckn.1.A | monomer | 0.71 | 94.12 | |||
| Isoform 16 | 7ysh.1.C | monomer | 0.72 | 77.88 | |||
| Isoform 16 | 1e0o.1.B | monomer | 0.70 | 60.75 | |||
| Isoform 17 | 2y8n.1.B | monomer | 0.58 | 37.04 | |||
| Isoform 18 | 7ysh.1.C | monomer | 0.73 | 77.21 | |||
| Isoform 18 | 1e0o.1.B | monomer | 0.70 | 60.47 | |||
| Isoform 19 | 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| Isoform 19 | 1ry7.1.B | monomer | 0.62 | 57.14 | |||
| Isoform 20 | 5a46.1.A | monomer | 0.76 | 1×38O; | 100.00 | ||
| Isoform 20 | 1ry7.1.B | monomer | 0.63 | 57.63 | |||
| Isoform 21 | 5a46.1.A | monomer | 0.75 | 1×38O; | 100.00 | ||
| Isoform 21 | 1ry7.1.B | monomer | 0.60 | 62.63 | |||